Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenstrom macroglobulinemia (WM): Results from iNNOVATE Meeting Abstract
| Authors: | Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; MacDonald, D.; Mahe, B.; Herbaux, C.; Heffner, L. T.; Tam, C. S. L.; Varettoni, M.; Palomba, M. L.; Matous, J.; Shustik, C.; Kastritis, E.; Treon, S. P.; Li, J.; Poulsen, E.; Hauns, B.; Buske, C.; Leblond, V. |
| Abstract Title: | Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenstrom macroglobulinemia (WM): Results from iNNOVATE |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 447s |
| Language: | English |
| ACCESSION: | WOS:000487345806345 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.8018 |
| Notes: | Meeting Abstract: 8018 -- Source: Wos |
